Private Market View

Ensoma

Drug Discovery · Boston, MA · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
$280.0M
Total raised
$258.0M
Last round
Later Stage VC (Series B1)
Sep 2025
What is Ensoma worth?
$280.0Mlast known valuation

Ensoma last raised $53.0M in its Later Stage VC (Series B1) (Sep 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·The complete investor list — 21 names
  • ·Watchlist + deal alerts for Ensoma
Create free account
No card required

Funding history

3 rounds
DateRoundRaisedPost-money
Sep 2025Later Stage VC (Series B1)$53.0M
May 2023Early Stage VC (Series B)$135.0M
Feb 2021Early Stage VC (Series A)$70.0M

How Ensoma's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Ensoma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Ensoma worth?
Ensoma's last known valuation is $280.0M.
How much has Ensoma raised?
Ensoma has raised $258.0M in total funding across 3 recorded rounds.
When did Ensoma last raise?
Ensoma last raised in Sep 2025 (Later Stage VC (Series B1)), raising $53.0M.